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Abstract
Background: The adult endocrine pituitary is known to host several hormone-producing cells regulating major
physiological processes during life. Some candidates to progenitor/stem cells have been proposed. However, not much
is known about pituitary cell renewal throughout life and its homeostatic regulation during specific physiological changes,
such as puberty or pregnancy, or in pathological conditions such as tumor development.
Principal Findings: We have identified in rodents and humans a niche of non-endocrine cells characterized by the
expression of GFRa2, a Ret co-receptor for Neurturin. These cells also express b-Catenin and E-cadherin in an oriented
manner suggesting a planar polarity organization for the niche. In addition, cells in the niche uniquely express the pituitary-
specific transcription factor Prop1, as well as known progenitor/stem markers such as Sox2, Sox9 and Oct4. Half of these GPS
(GFRa2/Prop1/Stem) cells express S-100 whereas surrounding elongated cells in contact with GPS cells express Vimentin.
GFRa2+-cells form non-endocrine spheroids in culture. These spheroids can be differentiated to hormone-producing cells or
neurons outlining the neuroectoderm potential of these progenitors. In vivo, GPSs cells display slow proliferation after birth,
retain BrdU label and show long telomeres in its nuclei, indicating progenitor/stem cell properties in vivo.
Significance: Our results suggest the presence in the adult pituitary of a specific niche of cells characterized by the
expression of GFRa2, the pituitary-specific protein Prop1 and stem cell markers. These GPS cells are able to produce
different hormone-producing and neuron-like cells and they may therefore contribute to postnatal pituitary homeostasis.
Indeed, the relative abundance of GPS numbers is altered in Cdk4-deficient mice, a model of hypopituitarism induced by
the lack of this cyclin-dependent kinase. Thus, GPS cells may display functional relevance in the physiological expansion of
the pituitary gland throughout life as well as protection from pituitary disease.
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Introduction
The pituitary gland is a central endocrine organ that regulates
basic physiological functions such as growth, stress response,
reproduction, lactation and metabolic homeostasis. The adenopi-
tuitary (AP) hosts several endocrine cell types secreting hormones
that regulate the function of other organs and endocrine glands
throughout life. Thus, somatotrophs, lactotrophs and thyrotrophs
secrete growth hormone (GH), prolactin (PRL), and thyroid-
stimulating hormone (TSH) respectively; corticotrophs secrete
adrenocorticotropic hormone (ACTH) and gonadotrophs secrete
luteinizing hormone (LH) and/or follicle-stimulating hormone
(FSH). In addition, some non-hormonal folliculostellate cells have
been described whose function is not well understood [1–3]. All
these cells in the AP arise during development from a common
ectodermal primordium known as the Rathke’s pouch [4].
However, not much is known on pituitary cell renewal throughout
life and its homeostatic regulation during specific physiological
changes such as puberty or pregnancy or in pathological
conditions such as tumor development. To explain these changes,
both cell proliferation of the individual differentiated secretory
cells and asymmetric proliferation followed by terminal differen-
tiation of adult stem cells have been proposed [5,6].
Although the identity of adult pituitary stem cells is not well
established, several stem/progenitor cell types have been previ-
ously proposed to maintain pituitary homeostasis and generate
endocrine cells. A side population (SP) that efficiently excludes the
Hoechst 33342 vital dye has been shown to segregate with sphere-
forming cells in the pituitary [7]. In addition, pituitary colony-
forming cells (PCFCs) that display notable clonogenic potential
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studied for these cells was Sca1 and their position in the pituitary
was not well understood [7,9]. Recently, the presence of Sox2+/
Sox92 of the mouse pituitary has been described and proposed to
mark stem cells, localized both as an epithelial layer but also
heavily intermingled with the differentiated cells [10], while more
differentiated progenitors or transit-amplifying cells would become
Sox2+/Sox9+. Genetic approaches using transgenic mice express-
ing GFP under the Nestin promoter identified a population of
Nestin+ cells that in vitro behaves as progenitors; however, these
cells would only contribute post-puberally to cell-renewal in the
adult pituitary [11].
In this manuscript we describe a niche of putative stem cells that
express the Glial cell line-derived neurotrophic factor (GDNF)
receptor alpha 2 (GFRa2). GFRa2 belongs to a family of receptors
(GFRa1-4) that modulate signaling pathways initiated by their
ligands, GDNF, Neurturin (NTN), Artemin (ART) and Persephin
(PSP). These proteins function as co-receptors of the tyrosine
kinase Ret [12–14]. GFRa2 functions as an specific NTN receptor
as demonstrated in vivo by the almost identical phenotype of mice
deficient in either NTN or GFRa2 [15,16]. In some tissues such as
testis and ovary, GFRa1 and 2 receptors are expressed in putative
germ-line stem cells [17–19]. In the pituitary, somatotrophs (GH)
are the only secretory cells expressing Ret and GFRa1 either in rat
[20] or in humans [21]. We report here that GFRa2 is expressed
in a niche of non-hormonal putative stem/progenitor cells in the
pituitary. GFRa2-positive (GFRa2+) cells are organized in a
single-cell layer around the cleft originated from the Rathke’s
pouch. These niche cells display a clear expression of the pituitary
specific homeobox protein Prophet of Pit1 (Prop1), a transcription
factor required for pituitary development and mutated in pituitary
disease [22–26]. In addition, these niche cells also express well-
established stem cell markers such as Oct4, Sox2, Sox9 and we will
refer to them as GPS (GFRa2+, Prop1+, Stem) cells.
Results
GFRa2 expression is mostly restricted to a polarized niche
in the pituitary
GFRa2 is expressed in the rat pituitary at similar levels to testis
(Figure S1A) or ovary (data not shown), two other endocrine
glands where GFRa1 and 2 receptors had been previously
described [17–19]. In the murine pituitary, GFRa2 expression is
restricted to a distinct subset of non-endocrine cells lined to a
single-cell layer in the marginal zone (MZ) around the cleft
between the intermediate lobe (IL) and the AP (Figure 1). The MZ
had been proposed to harbor stem/progenitor cells originated
from the Rathke’s pouch from which the endocrine cells could be
produced but still no clear proof has been found [5,9]. This layer
of cells opposed to the cleft originates, like the AP, from the
Rathke’s pouch formed from the oral ectoderm during embryonic
development. A very limited number of isolated GRFa2+ cells are
distributed throughout the AP (Figure 1A). In total, GRFa2+ cells
accounts for about 0.9% cells of the adult mouse pituitary (Figure
S1B). GFRa2+ cells do not express any pituitary hormone
(Figure 1B) but shows a significant expression of epithelial markers
such as Cytokeratins and E-cadherin (Figure 1C–D and Table 1).
These GFRa2+ cells also display a clear expression of b-Catenin
(Figure 1C –rat- and D –mouse-), whose labeling is rarely positive
in other cells of this endocrine gland (Figure S1-C). The GFRa2+
niche in the MZ seems to have a Planar Polarity organization.
Thus, the anti-GFRa2 antibody stains a very thin line in the
coronal axis of the MZ cells. However, GFRa2 stains broadly on
MZ cells in the axial axis. Similar polarization is found with b-
Catenin where each cell appears as a U-shaped line in coronal
sections versus complete rings in axial sections (Figure 1C and
Videos S1 and S2). Interestingly, the GFRa2 (membrane) and b-
Catenin (cytoplasm) signals are perpendicular (see Axial 4006and
10006sections), suggesting that the GFRa2 cell niche is formed of
cylindrical cells with Planar Polarity coordination, a specific
coordination of an epithelial layer of cells to behave with a
physiological direction (recently reviewed in [27].
GFRa2+ cells express pituitary specific factors and stem
cell markers in murine and human pituitaries
A variety of stem/progenitor cell markers is also expressed in
the niche of GFRa2+ cells (Table 1). Among them, the recently
described [10] Sox 2 and Sox9 transcription factors (Figure 2A –
mouse- and 2B-rat-) that co-stain with GFRa2/b-Catenin. These
cells also display a clear signal for Oct4 (Figure 2C).
GFRa2 cells does not express the pituitary specific transcription
factor Pit1 (Figure S2-A) but display a clear and specific signal for
Prop1 (Figure 2D). Prop1 is a transcription factor known for its
exclusive expression in pituitary development. Mutations in the
Prop1 gene cause hypopituitarism due to Combined Pituitary
Hormone Deficiency (CPHD) in humans [23] and the Ames
dwarfism in mice [22,25].
Based on the fact that GFRa2+ cells express a pituitary specific
factor, Prop1, with clear physiological relevance (see Discussion),
and bona-fide stem cell markers such as Sox and Oct4 proteins, we
call them GPS (GFRa2+, Prop1+, Stem). GFRa2+ cells also
express SSEA4 (Figure 2E), a glycolipid marker of embryonic stem
cells However, the niche of cells is negative for other stem markers
such as Nanog –expressed in the IL (Figure 2E) and S2B-, Sox4,
Isl-1 or Pax6 (Figure S2 and Table 1). Whereas the other co-
receptor, GFRa1, is not expressed in the GPS cells, they are
positive for the Ret receptor although with less intensity than
somatotrophs (Figure 2E and S2-C).
The calcium-binding protein S-100 (a marker of folliculostellate
cells [28–30]) is present in about 50% of GPS cells, in addition to
many scattered and elongated cells in the AP, MZ and IL
(Figure 2F). Another marker of folliculostellate cells, Vimentin
[31,32], delineates the GPS niche (Figure 2G). However, double
immunofluorescence with beta-catenin does not show the expected
co-localization. Vimentin+ cells appear as a line of elongated cells
posterior to the GPSs just before the IL both in rat and mouse
pituitaries (Figure 2G, H). Finally, Nestin, a marker of some
folliculostellate cells [33] is expressed in long and thin processes
through the AP, IL and NP similar to neurons or to folliculostellate
cells, but it does not correlate with GFRa2 staining (Figure 2I).
A similar niche of GPS cells, expressing GFRa2, Oct4, Sox2,
Sox9 and is also present in the MZ of the human pituitary around
the so called Rathke’s remnant cysts (Figure 3A–B). The human
pituitary also expresses Prop1 (Figure 3C). The niche of human
GPS is also partially positive for S-100 but negative for Vimentin,
which is expressed by elongated cells in the same area just in contact
with the GPS (Figure 3D). On the other hand, the GFRa2-specific
ligand NTN is exclusively expressed in groups throughout the AP
and not at the niche eitherin human orin ratpituitary (Figure 3E–F
and Figure S2-F). This finding, together with the planar polarity
found in the GPS niche, suggests a functional asymmetric signaling
in which the GFRa2/RET/NTN pathway may be implicated.
GFRa2+ cells form embryonic-like spheroids capable to
differentiate in hormone-producing cells
To address the differentiation potential of the GPS niche, we
isolated GRFa2+ individual cells and maintained them as a
A GPS Niche in the Pituitary
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2500 cells either GFRa2+ or GFRa22negative were seeded in a
35-cm-diameter dish (around 800 cells/ml). After seven days,
while the GFRa-negative dishes presented a few clumps of cells (12
clumps/dish, 4–8 cells/clump), the GFRa2+ cells formed spheroid
structures either compact or hollow with an empty cavity
surrounded by small cells (.139 spheroids/dish, around 40
cells/spheroid; average of more than 50 experiments). Some of the
spheroids contain cilia and display active movements (Figure 4A
and Videos S3, S4, S5 and S6). One of the roles of planar polarity
in embryogenesis is to induce oriented cilia during morphogenetic
migration, and functional defects in these cilia cause embryonic
abnormalities [34]. In humans, GPS are located around the
reminiscent Rathke’s cleft (see Figure 3), which has been described
to present cilia [35,36]. A benign non-neoplastic disease called
Rathke’s cleft cyst (RCC) is in fact characterized by a MZ cyst
pathognomonically surrounded by ciliated cells [37]. These cysts
are thought to originate from remnants of the Rathke’s pouch and,
in fact, their localization is similar to what shown in Figure 3 for
human GPS cells.
The spheroids actively divide up-to 50 cells (Figure 4B).
Opposite, the GFRa2 negative fraction maintained in parallel
remains as isolate cells with a few 4–8 cell clumps and does not
grow (BrdU-negative, Figure 4B, right, white bars). To demon-
strate that the spheroids are clonal, i.e. originate from a single cell,
we diluted the GFRa2+-cell suspension to 18 cells/ml and seeded
1 ml/well in the first column of a 24-well dish. Dilutions 1:2 were
performed in the next columns up to 0.5 cells/well. After five days
spheroids were carefully looked out and all of them photographed
to count approximately the number of cells per spheroid (Figure
S3-A, a representative experiment with quadruplicates is shown).
All the spheroids found were multicellular (ranging from 25 to
.100 cells/spheroid). The number of individual spheroids per
well were proportional to the number of individual GPS cells
seeded per well. Even diluting at 0,5 cell/ml we found near one
multicellular spheroid per well.
The spheroids maintain GRFa2 expression and display positive
labeling for Oct-4, Prop1, E-cadherin, and b-Catenin but are
hormone-negative (Figure 4C–D and Fig S3-B). The GFRa2
ligand, Neurturin (50 ng/ml) has a trophic effect in the spheroid
number when culturing in a diluted (0.56) SpherM (Figure S3-C)
indicating the GPS dependence of a functional RET/GFRa2/
NTN pathway. If the pituitaries are dispersed with trypsin (instead
of Collagenase) no single spheroid grows from the few GFRa2+
purified cells. This may be explained by possible deleterious effects
of trypsin in the extracellular domain of GFRa2. Similarly, if the
spheroids are dispersed with trypsin, they are able to make
secondary spheroids albeit the number of secondary spheroids
obtained was 1/3 of the number of GPSs seeded.
In the presence of gelatin and conditioned-media from MEFs
(50% MEFM), these GFRa2/Prop+ cells attach to the well and
grow slowly as a scattered culture (Figure S3-D). However, after
the second passage, differentiated structures as ‘‘cord-like’’
structures, colonies expressing red pigmentation or other kind of
defined-cells appear under the microscope intermingled with the
scattered GFRa2+ cells. We don’t know at present if the GPSs
have multipotent capacity. When the GPS cells are cultured on top
of mitomycin-treated MEFs in the presence of the characteristic
medium for Stem cells (StemM), they grow as undifferentiated
Table 1. Markers expressed by GFRa2+ cells.
Marker
% of GFRa2+ cells containing
the marker*
Hormones
GH 0%
ACTH 0%
PRL 0%
TSH 0%
FSH 0%
LH 0%
Epithelial markers and Wnt pathway
Multi-Cytokeratin 90%
E-cadherin 86%
b-Catenin 91%
GFRa2 pathway
Ret 78%
GFRa1 0%
NTN 0%
Stem cell markers
SSEA4 100%
Prop1 99%
Oct4 94%
Sox2 91%
Sox9 96%
Sox4 0%
Nestin 0%
Nanog 0%
Isl-1 0%
Pax6 0%
Other Markers
S-100 43%
Vimentin ,3%
Proliferation markers
Ki67 in adult GPS 0%
Ki67 at 10 days 13%
*Percentages are calculated counting cells from (confocal) microscopy pictures
(magnification higher than 4006). For each combination of markers, between
125 and 200 cells where counted from at least three independent pituitaries.
doi:10.1371/journal.pone.0004815.t001
Figure 1. GFRa2+-expressing cells form a line of epithelial non-secretory cells in the adult pituitary of rats and mice. A) Coronal and
axial sections stained with Hematoxylin and Eosin (H&E) to show pituitary location under the hypothalamus and on top of the sphenoid sella turcica
(Sc) and the disposition of the three pituitary lobes: adenopituitary (AP), intermediate lobe (IL) and neuropituitary (NP) where end-terminals of
hypothalamic axons release ADH and Oxytocin. In the rat pituitary, GFRa2+ cells (red) arrange in a precise line in the frontier between the AP and the
IL. Very few less intense cells are found dispersed through the AP (arrowhead). B) GFRa2+ cells [either lined or scattered (arrowhead)] do not express
any pituitary hormone. C) GFRa2+ cells are epithelial cells with enhanced expression of Cytokeratins, E-cadherin and beta-Catenin. Coronal versus
Axial sections demonstrates the orientation of the GFRa2 cells within the niche. In the coronal axis, GFRa2 or b-Catenin appear respectively as a thin
line or a U-shaped green staining; in the axial axis GFRa2 appears as a broad surface while b-Catenin shows a ring shaped staining in a perpendicular
orientation. D) Localization of GFRa2 cells and co-localization with E-cadherin and b-Catenin in mouse pituitaries.
doi:10.1371/journal.pone.0004815.g001
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presence of MEFM supplemented with LIF (ESGRO), these cells
do not attach to the gelatin-coated dish but grow as floating
spheres. We have been able to maintain these cultured GPS cells
either as attached/floating colonies or spheres at least up to the 7th
passage and still continue (Figure S3-E).
We next asked whether GFRa2+ spheroids maintain the
capability to differentiate to endocrine cells. Single spheroids were
isolated by pipetting under the phase-contrast microscope and
placed on Collagen Type IV coated wells, the collagen
characteristic of basal membranes from epithelial layers. We next
induced attachment with serum for one day, followed by
incubation in medium containing a specific combination of
supplements (DifM 1–4, see Methods). The spheroid got attached
during the first 24 hours of culture in presence of serum. From
that moment on, the cells start to attach to the dish and the
spheroid progressively disappears. Some of the cells migrate very
far away from the point where the spheroid attaches. If the
spheroid was big many cells appear on the dish; if the spheroid was
small less reduced numbers appear. That means that although we
Figure 2. The GPS Niche: GFRa2 cells express Prop1 and stem cell markers while neighbor cells express Vimentin. A) Detection of
Sox2 and Sox9 in the mouse and the rat pituitary (mSox2: mouse monoclonal and rSox2: rabbit polyclonal anti-Sox2 antibodies). (B). Sox2 signal co-
localizes with b-Catenin. C) In rat pituitary, Oct4 is also expressed in the same line of cells, and co-localizes with GFRa2. D) Co-localization between
GFRa2+ and Prop1 in the marginal zone between the AP and IL. Notice the nuclei positive for Prop1 surrounded by the GFRa2 membrane staining. E)
GFRa2 cells co-localize with SSEA4, a glycolipid characteristic of Stem cells, but not with Nanog, which is restricted to the IL. GFRa2 cells do not
express GFRa1 (which is however observed in somatotrophs) but weakly express the Ret receptor (Fig. S2). F) S-100 is expressed by the
folliculostelate cells of the IL and AP of rat pituitary, but is also concentrated in around half of the b-Catenin/GFRa2 cells. G) Vimentin, a mesenchymal
stem cell marker, is also expressed in the same niche as the GFRa2 cells but not in the same cells. Towards the IL, a parallel line of elongated cells
(arrows) just beyond the b-Catenin/GFRa2 cells (asterisks) can be observed; fixation provokes sometimes the separation of both lines of cells (right
panel). A similar Vimentin staining is seen in mouse pituitary (H). I) Although Nestin is expressed in the three portions of the pituitary, GFRa2 cells are
negative for Nestin expression. Thin structures similar to axons apparently coming from the Nestin+ neuropituitary contact the GFRa2 cells
(arrowhead).
doi:10.1371/journal.pone.0004815.g002
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the human pituitary with the anterior AP and a posterior NP; the boundary is called MZ and contains dilated structures usually called Rathke’s
remnant’s Cysts (RC). Cells lining the RC express GFRa2 and Oct4. B) These cells also express Sox9 and Sox2. The human pituitary also contains small
groups of Sox9+ or Sox2+ cells within the AP. C) Western blot detection of the pituitary specific factor Prop1 protein in rat (rAP) and human (hAP)
pituitary, but not expressed in HeLa cells or a somatotroph pituitary cell line (GH4C1). D) S-100 is expressed in around half of the human GFRa2 cells
lining the RC, similarly to what observed in the rat pituitary. Similarly, Vimentin+ elongated cells surrounded the GFRa2 epithelium (right panel). E)
The GFRa2 ligand NTN is expressed in the human and rat (F) pituitary, and localizes exclusively at the AP.
doi:10.1371/journal.pone.0004815.g003
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attachment/differentiation we have the repeated impression from
the many experiments that the differentiated cells do not
proliferate. Using this approach, we were able to differentiate
these spheroids into GH-, PRL-, TSH-, ACTH-, or FSH-
producing cells (Figure 4E). We did not observed any cell positive
for GFRa2 or Prop1 after differentiation (Table 2). When
spheroids are seeded on top of Poly-L-lysine with DifM4,
Tubulin-beta-III positive cells are observed. Tubulin-beta III is
characteristic of neurons and in fact some of these cells present
bipolar appearance (Figure 4F), suggesting an ectodermal stem cell
potential for pituitary GRFa2+ cells. Similar results were obtained
using the characteristic neuronal intermediate filament protein
Neurofilament (NF).
To evaluate RNA expression throughout the differentiation
process, we performed RT-PCR analysis in the GFRa2+ fraction
(90% pure), the GFRa2-negative fraction (95% pure), in both
fractions 5 days after culture in SpherM (when there is a spheroid-
enrichment in the GFRa2+ fraction), and in the cells obtained
after differentiation of a single spheroid in DifM4 (Figure 4G).
GPS stem markers are strongly expressed in the GFRa2+ fraction
and absent in GFRa2-negative cells. In parallel, GH expression is
Figure 4. Purified GFRa2+ cells form embryonic-like spheroids that differentiate into different ectodermic cell types. A) Rat AP single-
cell dispersions are prepared by treatment with Collagenase. The two fractions obtained, a GFRa2+ purified fraction (90% positivity for GFRa2 by
immunofluorescence) and the Flow through GFRa2- (95% negativity for GFRa2), are then kept in SpherM. After 7 days, spheroids formed by small cells
are observed in the GFRa2+ fraction. Some of they contain a hollow cavity while others are compact. A bunch of moving cilia is frequently observed
in one pole of these spheroids (arrows; see videos in Supplementary Information). AP cell dispersion with trypsin does not result in viable spheroids
as GFRa are extracellular receptors sensitive to trypsin treatment. B) Proliferation in the GFRa2+ and GFRa2- fractions after 5 days in the presence of
BrdU. Center: A 7-day-old spheroid incubated with BrdU only for the last 12 hours before fixation. Right: BrdU uptake within growing spheroids
incubated with BrdU during the last 12 hours before fixation. C) The spheroids are clonal (see Figure S3-A) and express GFRa2, Oct4, Prop1 or E-
cadherin. D) These structures express b-Catenin but not hormones such as GH, PRL (and S3-B) or ACTH (data not shown). E–I) A single spheroid was
transferred under the microscope to a collagen/poly-lysine-coated well and attached to the matrix with serum for 24 h. Spheroid structure disappear
and cells spread through the well. Cells differentiate depending on the culture conditions into E) different pituitary secretory types (intermediate
nuclei) or F) neurons (small or big nuclei) showing Tubulin beta III-+ cells+ or NF+ cells. G) mRNA expression of GFRa2/Prop1/Oct4 in the GFRa2+
purified fraction. The GFRa2+ fraction still have some contaminating secretory cells expressing GH. Five days later (spheroids) RNA expression of
GFRa2 shifted (alternative splicing) while Prop/Oct4 were negative (even if the proteins were present). 14 days after differentiation of a single hand-
picked spheroid, expression of either secretory (GH) or neuronal (Tubulin b-III) differentiation markers is detected. H) Double immunofluorescence in
differentiated spheroids showed that differentiation is most frequently driven towards either secretory or neural phenotype. I) However, in some
wells double GH/NF+ cells (orange arrows) together with single GH+ (red arrows) or NF+ (green arrows) or negative (white arrows) cells coexisted
(Table 2).
doi:10.1371/journal.pone.0004815.g004
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somatotrophs in the pituitary (10% contaminating GFRa2-cells).
After culturing in SpherM medium, expression of GPS markers
decay although the proteins are still present in the spheroids, and
GFRa2 band shifts to a different spliced band. No differentiation
markers, Tubulin-beta III, or a very weak band of GH can be
detected. It seems that the GPS cells in the spheroid structures
start to change its characteristics but need later inputs from
different ligands (present in the various DifM) to get differentiated;
some of these differences are downregulation of Oct4, Prop1
mRNA expression or alternative splicing of GFRa2 mRNA. In the
GFRa2- fraction (95% GFRa2-) with days positivity for GFRa2
and Prop1 mRNA appear demonstrating the self-renewal capacity
of the few remaining GFRa2+ cells.
When the spheroids are induced to differentiate, no GPS
markers are detected but GH and Tubulin-beta III are expressed
de novo. In our hands, differentiation protocols are quite specific
since lactotrophs (PRL) are only obtained with DifM 3, whereas
GH was never detected in this medium (Table 2). When two
markers were simultaneously analyzed in the same well, the
majority of differentiated cells are positive for one marker and
there was only one type of differentiated cell (blue on Table 2,
Figure 4F and H-left). However on occasion two types of
differentiated cells co-existed on the same well (green on Table 2,
Figure 4I, lower magnification), and even there were some cells
positive for two hormones or for GH and NF (pink on Table 2,
Figure 4I, higher magnification). In general, positivity for
hormones is linked to a nucleus of intermediate size; positivity
for NF correlates with a nucleus of small size; and positivity for
Tubulin-beta III is frequently observed in cell with a large nucleus.
Slow proliferation and long telomeres in the GPS niche of
adult animals
In vivo the stem cells are slow cycling cells that retain the
nuclear DNA label of infancy into adult age as demonstrated for
mouse skin, mammary gland, endometrium and liver [38–41], or
Table 2. Summary of all the differentiation experiments with the 5 differentiation media (DifM1-5)*.
GH PRL bTSH ACTH bFSH Tub b III NeuroF
nu+ nuclei nu+ nuclei nu+ nuclei nu+ nuclei nu+ nuclei nu+ nuclei nu+ nuclei
DifM1 n.t. n.t. 0 10 n.t. n.t. n.t.
93 8
10 18
DifM2 1(1) 25 5( 1 ) 25 n.t. n.t.
1(1) 52 12(1) 52
01 7
01 7
6 (0) 29 0 (0) 29
7 (0) 9 0 (0) 9
8(0) 27 0 (0) 27
3(2) 58 2( 2 ) 58
DifM3 0 (0) 17 6 (0) 17 n.t. n.t. n.t. n.t.
01 5
6(a)5 1
0( b)1 8
2(a)3
01 3
DifM4 (Polylysine) n.t. n.t. 5 15
26(0) 27 1(0) 27
7 (0) 28 0 (0) 28
6(5) 93 10(5) 93
3 (0) 9 0 (0) 9
7 (0) 37 0 (0) 37
0 (0) 117 2 (0) 117
0 (0) 50 1 (0) 50
0 (0) 25 24 (0) 25
01 8
DifM5 n.t. n.t. n.t. n.t. 2 31 n.t. n.t.
*A single isolated spheroid was induced to attach to the gelatine-coated (DifM1,2,3 and 5) or poylysine-coated (DifM4) well with serum for one day, and induced to
differentiate during 15 days in the presence of any of the DifM 1 to 5. Wells were fixed and immunofluorescence performed. In some wells double immunofluorescence
was performed (aligned in the same row): those wells where more than one cell type co-existed are written in bold and the number of cells double positives for both
markers is shown in brackets; those wells where one single type of cell was detected are in italics. In some of the wells (underlined), co-immunofluorescence for GFRa2
(a)o rP r o p( b) was performed, always with a negative result.
doi:10.1371/journal.pone.0004815.t002
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in newborn-rat pituitaries (Figure 5A). GRFa2+ cells actively
divide during early postnatal development but loose proliferative
potential with age, as detected by Ki67 staining of the GPS niche
(Figure 5A and B). Also in adult mouse pituitaries, cell division is
scarce and rarely observed in GPS cells (Figure 5C), thus
suggesting that GPSs were slow cycling cells in vivo. In parallel,
the expression levels of stem cell markers in the AP decrease
during postnatal development to adulthood in an inverse
correlation with the production of hormones or the Pit1
transcription factor (Figure 5D), implying a division of stem cells
to increase pituitary mass. To analyze the frequency of replication
in the putative stem cell niche, we used the BrdU retaining
technique. In rats, GRFa2+ cells specifically retained BrdU even
60 days after an injection when newborns whereas this signal was
lost in most of the other cells in the pituitary (Figure 5E). These
results suggest that the niche of GFRa2 cells replicates slowly after
birth, a property shared by most progenitor/stem cells.
Slow replication is linked to long telomeres and these two
features are a hallmark of stemness [44–46]. Mature cells have
usually undergone many divisions and telomere length gradually
decreases with each cell cycle due to incomplete replication of
telomeric DNA. We have used a novel technique, ‘‘telomapping’’,
to quantify the length of telomeres in situ based upon the specific
in-situ hybridization of a fluorescent telomeric DNA probe on
paraffin sections. The longest telomeres in the pituitary specifically
mark the marginal zone within the IL/AP boundary where GPS
cells are located (Figure 5G). Progressive rows of cells towards the
AP or NP present less intense signals (orange) while the mature
secretory cells in AP have the faintest signal (green) corresponding
to short telomeres. These results suggest that progenitor cells in the
pituitary are located to the MZ where GPS localize. On the other
hand, most cells in the AP display short telomeres suggesting an
abundant component of mature cells that have undergone many
cell divisions.
Altered cell cycle regulation of GPS cells in genetically-
modified mouse models with hypo- or hyperplastic
pituitaries
Proliferation in the progenitor/stem cell niches depends on
Cdk4 activity, being carefully downregulated within the niche and
increasing when the progenitor cell enters in the so-called transit-
amplifying state to become differentiated [47]. Cdk4-deficient
mice in which Cdk4 has been inactivated by the insertion of a
neomycin-resistant (neo) cassette [Cdk4(n/n) mice] [48] display
hypoplastic pituitaries with a dramatic decrease of all hormone-
secretory cells in the AP during postnatal life (Figure 6A–B, center
and Figure S4). These Cdk4-null pituitaries display normal Ki67
staining during embryonic development but a decreased prolifer-
ation after birth (data not shown), similarly to that we have
previously observed in Cdk4-null endocrine cells in the pancreas
[49]. Yet, the ratio between GPS cells and total number of cells in
the pituitary was not only maintained but enlarged in these
animals suggesting normal production of these cells during
embryonic development but abnormal differentiation into hor-
mone-producing cells. Thus, whereas wild-type mice contain
about 0.9% of GPS cells (see Figure S1), these cells display a
relative 3-fold enrichment in Cdk4(n/n) mice (Figure 6C).
Moreover Cdk4-null pituitaries display long telomeres throughout
the AP (Figure 6D), suggesting a reduced number of cell cycles in
these small anterior pituitaries. Hypoplastic Cdk4 KO pituitaries
do not exhibit an enriched ‘‘niche’’ in absolute terms. The niche is
relatively enriched considering the reduced number of endocrine-
producing cells. The interpretation is in keeping with the concept
that most defects in stem cell proliferation result in a defect in
differentiated cells without affecting the stem compartment. A
similar situation has been found previously in the hematopoietic
compartment of Cdk4/6 deficient embryos [50].
Interestingly, these three phenotypes (reduced pituitary size and
cellularity, relative increase in GPS cells and long telomeres in the
AP) are rescued when Cdk4 is re-expressed [Cdk4(R/R) mice] by
expressing Cre recombinase and removing the neo cassette
(Figure 6A–D, right panels), in parallel with the recovery of
normal pituitary function (Figure S4). These results suggest that
Cdk4 participates in the control of postnatal proliferation and/or
differentiation of GPS cells.
Discussion
The existence of a primordial cell in the pituitary was proposed
more than ten years ago when exceptional human pituitary
adenomas were observed to concomitantly express Pit1-dependent
hormones (GH, PRL and TSH) plus ACTH and gonadotrophic
hormones [51–53]. More recently, the presence of stem cells in the
pituitary has been suggested in dispersed cultures isolated by
citometry as a Side Population (SP cells) of mouse pituitary cells
positive for Sca1, Nestin, Nanog and Oct4, but negative for Prop1
[7]. Additional progenitor cells have been also proposed as a
colony-forming population of Sca1+ and angiotensin-converting
enzyme (ACE)-+ cells [9]. Some of the later were in fact located to
the MZ of the pituitary. The MZ had been proposed to harbor
stem/progenitor cells originated from the Rathke’s pouch from
which the endocrine cells could be produced [1,9]. Recently,
Sox2+/Sox92 cells have been found in the mouse MZ but also
strongly dispersed throughout the pituitary intermingled with
secretory cells [10]. A population of Nestin+ cells has been traced
after birth in the pituitary in vivo [11]. Nestin+ cells were found in
the three parts of the pituitary, and only a small population of the
adult secretory AP cells was originated from these Nestin+ cells
postpuberally, more than 2.5 months after birth. At present, it is
unclear whether the growth of the pituitary after birth or
maintenance of the adult population of secretory cells requires a
single or several types of progenitor/stem cells.
We have characterized a specific cell population in the MZ of
the rodent –rat and mice– and human pituitary, initially identified
by the expression of the GFRa2 receptor. These cells exhibit
unique features, i.e. not present in other pituitary cell-types, such
as the presence of GFRa2 receptors, the expression of the pituitary
specific transcription factor Prop1, and the presence of additional
stem cell markers such as Sox2, Sox9, SSEA4 and Oct4. The
presence of these markers, long telomeres, and the in vitro
potential of GPS cells to differentiate in all AP endocrine cells
make them strong candidates for the maintenance of differentiated
cells on the pituitary. GPS cells are Nanog/Nestin-negative but
similar Oct-4+ Multipotent Adult Progenitor Cells (MAPCs) have
been reported to be negative for other embryonic stem cell
markers such as Nanog or Sca1 [54]. SSEA-4 is an embryonic
stem cell marker in humans but it is not present in mouse
embryonic stem cell lines, which are instead positive for SSEA-1.
There is not known in much detail what markers are present on
the surface cells of the early rat embryo stages, if they would be
lacto-series of glycolipids (SSEA-1) as in mouse or globo-series of
glycolipids (SSEA-3 and SSEA-4) as in humans. Rat embryonic
stem cells recently obtained expressed SSEA-4, SSEA-3 and
SSEA-1 on top of Oct4 or Nanog [55]. In agreement with these
results, it was known that a small percentage of rat Dorsal Root
Ganglia (DRG) ‘‘small’’ precursors were positive for SSEA-4 [56].
The DRG is one of the niches where neural crest progenitors/stem
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mouse vs. human difference present into embryonic stem cells,
changes in adult stem cells. Recently, it has been demonstrated
that hematopoietic stem cells are positive for SSEA-4 (and Sca1
positive but c-Kit/CD45/Flk-1/and SSEA-1 negative) both in
mouse and in human and, in fact, SSEA-4 has been proposed to
better purify HSCs from the bone marrow [58].
Adult stem cells divide infrequently and reside in protected
microenvironments or niches [59] with a low rate of telomere
erosion throughout their life-time. These niches can be either
acellular or contain other cell types that give support to the stem cell
niche [60]. The presence of Vimentin+ cells near the GPS cells in
both rodent and human pituitary suggests the presence of a cellular
stem cell niche on the pituitary. GPS cells also express E-cadherin
and b-Catenin in a polarized manner (coronal vs. axial) surrounded
by Vimentin+ cells, suggesting a putative relation with the known
function of the Wnt/b-Catenin pathway together with E-cadherin
to retain the stem cells within the niche confines [60]. Future studies
Figure 5. GFRa2+ niche is present at birth and maintained through adulthood with reduced proliferation and long telomeres. A)
Newborn (24 h) and 10-days (10 d) old rat pituitaries present a GFRa2+/b-Catenin+ but GH- niche similar to that adult pituitaries (60 to 90-days old).
B) 10 d pituitaries display abundant cell proliferation in the GPS niche, as seen by Ki67 staining, opposite to the adult rat (60 d) or mouse organs (C).
D) Expression of GFRa2, Oct4, Prop1, GH, Ret and Pit1 in the AP of newborn and 10-, 20-, 30- and 60-day-old rats as detected by qRT-PCR. GPS
progenitor markers (GFRa2, Oct4, Prop1) decrease with age while somatotroph markers (Ret, Pit-1) peak around puberty, day 10 to 20, or increase
with grow to adulthood (GH). E) BrdU retaining in the GPS niche (arrows). Adult-pituitary nuclei within the niche retain BrdU injected in the rats as
newborns. Three different animals (1–3) are depicted in the figure. F) Telomapping analysis of normal mouse pituitaries demonstrates a thin line of
very long-telomere containing nuclei exactly in the first row of cells at the IL/AP boundary (regions I) matching the GPS niche. The following rows of
cells towards the AP or the IL/NP present a shortening of the telomeres while the bulk of secretory cells have short telomeres characteristic of
differentiated cells. G) Normal pituitaries were stained with H&E, Sox2 or Sox9 showing the GPS cells in the AP/IL boundaries (AP region I and IL
region I) and some scattered groups through the AP (mostly in region III of the AP). Telomapping analysis as quantified in H) indicates that the region
I of AP contains most long-telomere cells. This percentage progressively decreases in region II and III, where scattered GPS cells with long telomeres
are found. In the IL, the only cells with long telomeres are also located in region I of the IL. AP, adenopituitary; IL, intermediate lobe; NP,
neuropituitary.
doi:10.1371/journal.pone.0004815.g005
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clearly merited. Perpendicular staining of GFRa2 versus b-Catenin
within the GPS niche reminds of planar polarity, a specific
coordination of an epithelial layer of cells to behave with a
physiological direction (recently reviewed in [27,61]. It is therefore
not casual that isolated GPS cells in culture form moving
embryonic-like spheroids and present specialized cilia. One of the
roles of planar polarity in embryogenesis is indeed to induce
oriented cilia during morphogenetic migration to prevent embry-
onic abnormalities [34]. The planar polarity in the GPS niche also
suggests a functional asymmetric signaling in which both the
GFRa2 and Wnt pathways may be implicated. Thus, the Ret/
GFRa2 pathway may help to indicate the cells in the niche the
correct side to migrate and/or to proliferate. The expression of the
ligand NTN in discrete cells through the AP but not in the niche
cells adds an interesting suggestion of luring the GPS cells out of the
niche through a guiding gradient. This situation is reminiscent of
the niche present in the seminiferous tubules of the testes where Ret
and GFRa1/GFRa2, along their ligands GDNF and NTN, play an
important role in the interplay between multipotency versus
differentiation of the germ stem cells [18,19,62]. Similarly, in the
pituitary, the NTN/GFRa2 axis may modulate stem/progenitor
physiology whereas Ret/GFRa1 system controls somatotroph
differentiation and fate (death versus survival) through Pit1
regulation as we have described previously [63].
Some additional genes expressed by the GPS niche, such as Sox
proteins or Prop1, have important roles in pituitary physiology and
disease. Mutations in the Sox2 gene cause pituitary hypoplasia
associated with hypogonadotrophichypogonadismand eye, ear and
encephalic abnormalities [64–67]. Ames dwarf mice and Prop1 null
mice have a normal pituitary volume at birth but the organ does not
grow nor differentiate in postnatal life. Similar phenotype have the
patients affected by Combined Pituitary Hormone Deficiency
(CPHD) [23], a hypopituitarism caused by mutations in Prop1 [68]
where there pituitary undergo progressive hormone loss suggesting
a depletion of progenitors. Patients with CPHD display a general
loss in all types of secretory cells, but affecting more those that are
required throughout growth and puberty (GH, LH/FSH) and
metabolism (TSH). Although initially it may be not present, delayed
ACTH deficiency also appears [69]. Some patients present with
hyperplasia of the pituitary while others display hypoplastic
pituitaries; moreover, it is currently accepted that enlargement of
the pituitary precedes the hypoplasia [69,70]. Ames dwarf mice
have a slightly different phenotype, with the predominant failure in
the Pit1-dependent secretory types (GH, PRL, TSH) and
apparently not deficiency in gonadotrophs/corticotrophs [22,71].
Since this in a spontaneous mutation we cannot be sure of the
genetic background. However, Prop1-deficient mice have display a
phenotype similar to the human CPHD, including gonadotroph
deficiency [25]. Both Ames dwarf and Prop1-deficient mice have a
normal (or only slightly decreased) pituitary at birth, suggesting a
defect in adult homeostasis. Moreover, Prop1 transgenic mice have
a delayinpuberty[72].Prop1 inthe pituitaryembryonicprogenitor
cells of the Rathke’s pouch is considered to play a role in the
migration process of the progenitor cells out of the marginal zone
[26,73]. Our data demonstrate that Prop1 expression in the adult
pituitary is restricted to the GPS niche. It is tempting to speculate a
role for Prop1 in protecting the stem cells and correctly guide them
through asymmetric division/differentiation when needed. A
detailedstudyofthenicheintheseanimalmodelswillbeperformed.
Interestingly, the pituitary deficiency induced by Prop1
mutations is reminiscent of the hypopituitarism induced by
inactivation of the cell cycle regulator Cdk4 ([74] and Figures 6
and S4). GPS cells are present in this model although
accompanied by an overall decrease in endocrine producing cells.
These AP cells display longer telomeres suggesting a defective
number of cell divisions from their progenitor cells. Interestingly,
GFRa2-deficient mice display a significant failure to thrive after
weaning although the involvement of pituitary function in this
phenotype has not been addressed [16]. Also similarly to Cdk4,
persistent Prop1 expression in the mouse delays endocrine
differentiation and enhances tumor susceptibility [72] (see below).
The initial Rathke’s pouch, as well as the encephalic neural
tube, comes from the anterior ectoderm. GFRa2+ spheroids are
able to differentiate to secretory pituitary cells but also towards
neuron-like phenotypes when driven appropriately with a specific
differentiation medium. A similar induction of neuronal pheno-
types from epithelial stem cells of the inner ear has been
demonstrated ([75]. Similarly, pituitary secretory cells can be
obtained from neuronal fetal progenitors [76] and many human
pituitary adenomas present with neural metaplasia [77]. However,
the GPS are able to remain undifferentiated when grown in
conditioned-medium from MEFs; in this conditions, however, part
of the cells differentiate spontaneously with passages. GPS remain
undifferentiated and form colonies when grown directly on top of
MEFs or when grown in the presence of ESGRO (LIF), a feature
shared by all stem cells described.
All together, our results suggest that GPS cells may have
relevant contributions to postnatal pituitary homeostasis. These
cells a likely to form a functional niche of adult precursor cells with
functional relevance in the physiological expansion of the pituitary
gland throughout life as well as protection from pituitary disease.
Materials and Methods
For a detailed list of methods and antibodies and dilutions see
Supplementary Methods S1 and Table S1, S2 and S3.
Human and murine samples
Rats were obtained from the Central Animal House of the
USC, a registered animal facility that maintains the animals under
welfare and ethical conditions complying with the 86/609/CEE,
RD223/88, and OM 13/10/89 laws. The project had the
approval of the Ethical Committee of the USC. Rat pituitaries
were obtained from adult (200–250 gr., 60 days) male/female
Sprague-Dowley rats. To study expression during postnatal
development newborns, 10, 20, 30 and 60 days old male rat
pituitaries were compared.
Figure 6. Increased relative abundance of GPS progenitors and decreased formation of endocrine cells in Cdk4–null mice. A) Alleles
used in the analysis of GPS cells in a hypopituitarism model. The Cdk4-null allele Cdk4(n) is obtained by insertion of a neo-resistance cassette in Cdk4
intron 1. This mutation is rescued by expressing, through Cre recombination, a Cdk4
R24C mutant allele that encodes a hyperactive Cdk4 [48]. B) Cdk4-
null mice display a hypoplastic pituitary much smaller than the wild type due to low cellularity and smaller size. These differences mostly affect the
AP, containing around 5% cells of the wild-type pituitaries by 2-month age. This phenotype is rescued in the Cdk4(R/R) which displays a bigger
pituitary with a 2-fold increase in the AP by 2-months. C) Genetic ablation of Cdk4 does not affect the structure of the stem cell niche. Moreover, the
relative abundance of GPS cells is enlarged presenting more cell layers and 3–3.5-fold more GPS cells in the AP and 2-fold in the IL. D) The overall
length of telomeres is significantly increased in the Cdk4-deficient AP distal region III. About 48% of these cells display long telomeres whereas this
number is about 12% in wild-type or Cdk4
R24C-rescued AP. AP, adenopituitary; IL, intermediate lobe; NP, neuropituitary.
doi:10.1371/journal.pone.0004815.g006
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Department of Pathology, Hospital Universitario Virgen del Rocı ´o
(Sevilla, Spain). Informed consent was required from patients
according to the policies of the Ethical Committee of the Hospital.
Generation and characteristics of the Cdk4-deficient mice has
been previously described [48,78–80]. The Cre strain used was
CMV-Cre [48]. Mice were maintained in a mixed 129/
Sv6C57BL/6J background following the institutional guidelines
at the Spanish National Cancer Research Center (CNIO) and the
protocol approved by the Committee of Bioethics and Animal
Care of the Comunidad de Madrid. The animals were observed in
a daily basis and sick mice were euthanized humanely in
accordance with the Guidelines for Humane End Points for
Animals used in biomedical research.
Immunodetection
For immunofluorescence, rat pituitaries were oriented and
immersed in an OCT-filled plastic cryomold (Sakura) and frozen
inside a glass beaker filled with isopentane previously immersed in
liquid N2; frozen cryomolds were maintained at 280uC until
sectioned in 10 microns cryosections. The sections were fixed with
0.1% Paraformaldehyde for 10 minutes (GFRa2, Prop-1, Oct-4,
Citokeratins, E-cadherin, SSEA-4, rabbit Sox2, Nanog, Nestin,
ACTH, PRL, FSH, LH) or with -20uC methanol for 5 minutes
(GFRa2, Prop-1, Oct-4, b-Catenin, rabbit anti-Sox2 (rSox2),
Nanog, Ret, GFRa1, GH, TSH) or 0.5% paraformaldehyde for
20 minutes (GFRa2, GH, Ki-67); for mouse anti-Sox2 (mSox2)
and Sox9 the pituitaries were fixed in 4% paraformaldehyde
overnight before freezing and sectioning. Alternatively, cryosec-
tions were fixed in 4% paraformaldehyde for at least 10 minutes.
Primary antibodies were applied overnight in PBS, thoroughly
washed in PBS followed by 1 hour incubation with secondary
antibodies, washing and mounted using GelMount (Biomeda).
Guinea pig polyclonal antibody anti- Prop1 was made in house
against the carboxy-terminal domain of mouse Prop-1. cDNA
encoding amino acids 151 to 223 were cloned downstream of
either a GST or a His-tag vector. Fusion proteins were expressed
in BL21 E. coli and partially purified over glutathione agarose
(Sigma) or Ni2+-NTA-agarose (Qiagen). Initial immunizations
were performed with GST-Prop-1 fusion protein and the final
boosts were performed with the His-Prop-1 fusion proteins. It has
been already demonstrated that this antibody recognizes Prop1
transcription factor in mouse E12.5 [81]. Double immunofluores-
cences were performed in consecutive days; to prevent secondary
antibody backgrounds, the order was dependent on the species of
the primary antibody: first day goat, guinea pig or rabbit, second
day rabbit or mouse respectively. Negative (using PBS instead of
primary antibody) and preadsorption (competing with cold
peptide/protein) controls were routinely run in parallel (see
Supplementary Methods S1). Nuclei were counterstained with
20 mg/ml DAPI (Sigma). A TCS-SP2-DMRE Confocal Micro-
scope with Ar, He/Ne 543 and He/Ne 633 Lasers (Leica) and
LCS software was used to analyze the results.
For immunocytochemistry and telomapping, mouse or human
pituitaries were fixed in 10% buffered formalin at 4uC, dehydrated
through graded alcohols and xylene, and embedded in paraffin.
Prior to embedding, pituitaries were oriented in order to obtain
specific sagittal or coronal 5 microM sections. Prior to IHC,
paraffin-embedded slides were de-paraffinized, re-hydrated, im-
mersed in 10 mM citrate solution and epitopes retrieved by three
high-power, 5 min microwave pulses. Slides were washed in water,
blocked in 1:10 dilution of normal goat serum (Vector Labs) and
incubated with primary antibodies. Slides were then incubated
with secondary biotinylated antibodies followed by signal devel-
opment with an immunoperoxidase reagent (ABC-HRP, Vector
Labs) and DAB (Sigma). Sections were lightly counterstained with
hematoxylin and analyzed by light microscopy.
For immunoblotting, tissues o cells were lysed as previously
described [63,82].
Isolation and culture of GFRa2+ cells
A detailed protocol is provided as Supplementary Information.
Briefly, freshly isolated cell suspensions were prepared from male
rat or mouse pituitaries using magnetic activated cell sorting
(MACS; Miltenyi) or a fluorescence-activated cell sorter (FACS;
FACSAria, Becton-Dickinson). The experiments with spheroids
shown in the Figures 4 and S3 were performed with rat cells,
although many have been reproduced in mouse cells (data not
shown).
GFRa2+ purified cells were cultured in un-coated wells in the
presence of SpherM. After 5–7 days spheroids were either video-
recorded or fixed for further immunofluorescence or induced to
differentiate. For the BrdU-uptake experiments, 10 microM BrdU
(Sigma) was added from the beginning, but a toxic effect was seen
with longer treatments than 5 days; to evaluate the % of cell
division in spheroids of different days BrdU was added for the last
12 hours of incubation before fixation. To differentiate each
spheroid was carefully picked with a P1000 pipet under the
microscope and placed in poly-L-lysine or Collagen type IV
treated Cultureslides (BD) in 10% FCS-SpherM. The following
day, the medium was replaced during 14 days by any of the
differentiated media DifM 1–4. Immunofluorescence of spheroids
was performed pipetting them on top of 8 microM inserts
(Millipore) and fixing them with 70% Ethanol at room
temperature during 30 minutes, plus 4 M HCL during 20 minutes
(BrdU labeling) or with 220uC Methanol for 5 minutes for the
other antibodies before proceeding as above. Differentiated cells
were fixed in Methanol (hormones) or in 4% paraformaldehyde
for 20 minutes (hormones, Tubulin-beta III, NF).
BrdU retaining technique
Three days old rats were injected subcutaneously with 50 mg/g
BrdU (Sigma) in 0.9% NaCl twice/day during 3.5 days. 60 days
later, animals were sacrificed and pituitaries frozen as above.
Cryosections were fixed in 220uC Methanol for 10 minutes,
washed and incubated in 4 M HCl for 20 minutes. After washing,
immunofluorescence with anti-BrdU (BD) was performed as
above.
Confocal quantitative telomere FISH (Telomapping)
For telomapping, paraffin-embedded tissue sections were
hybridized with a PNA-tel Cy3-labelled probe and telomere
length was determined as described [46]. DAPI, Cy3 signals were
acquired simultaneously into separate channels using a confocal
ultraspectral microscope (Leica TCS-SP2-A-OBS-UV) using a PL
APO 206/0.70 PH 2 as lens with Leica LCS software and
maximum projections from image stacks (10 sections at steps
1.0 microM) were generated for image quantification. The DAPI
image was used to define the nuclear area and the Cy3 image to
quantify of telomere fluorescence. The binary DAPI mask was
applied to the matching Cy3 to obtain a combined image with
telomere fluorescence information for each nucleus. Cy3 fluores-
cence intensity (telomere fluorescence) was measured as ‘‘average
gray values’’ (total gray value/nuclei area) units (arbitrary units of
fluorescence). These ‘‘average telomere fluorescence’’ values
always represent the average Cy3 pixel intensity for the total
nuclear area, and not the average value of individual telomere spot
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influence telomere length measurements.
Supporting Information
Figure S1 Expression of GFRa2 and b-Catenin in the
adenopituitary A) GFRa2 mRNA expression in the rat adenopi-
tuitary (AP) is comparable with the testes, a gland well known for
its GFR alpha expression. B) GFRa2 stains about 0.9% of all AP
cells detected by flow cytometry after specific binding of anti-
GFRa2 antibody. The enzyme dispersed suspension of mouse-
adenopituitary cells were sequentially incubated with anti-GFRa2
antibody followed by FITC-anti-rabbit antibody (see Supplemen-
tary Tables S1 and S2). The cell suspension was analyzed by
cytometry; in red the analyzed FITC+ population and in blue the
sorted population presenting the strongest FITC signal. In the
negative control (only Ig, secondary antibody) this population was
less than ,0.1%, while in the GFRa2+ samples accounted for
around 0.9% of the total cell suspension. The GFRa2+ population
is composed of homogeneous small cells as seen by the low level of
the sorted population on the FSC in comparison with the non-
FITC population or with the faint FITC+ within the control. C)
Low magnifications of a whole section of a rat pituitary (DAPI)
and the b-Catenin enrichment at the niche between AP and IL.
The only pituitaries small enough to picture like this were from 10-
days old rats. AP, adenopituitary; IL, intermediate lobe; NP,
neuropituitary.
Found at: doi:10.1371/journal.pone.0004815.s001 (0.92 MB
PDF)
Figure S2 The GPS niche is weakly positive for RET but does
not express Pit-1, Nanog, GFRa1, Nestin or Sox4. A) The GPS
niche is negative for Pit1, a pituitary transcription factor expressed
by somatotrophs (GH), lactotrophs and thyrotrophs, as is negative
for GH. B) The GPS niche is also negative for Nanog. Nanog
staining is only observed in the IL and does not overlap with b-
Catenin at the niche. C) The Ret tyrosine-kinase receptor stains
specific cells in the AP (mostly somatotrophs, [1,2], and it is also
expressed in neurons of the NP. It also weakly stains the GFRa2+
niche; however the GPS cells are negative for GFRa1. D) The
Nestin+cells of the pituitary are dispersed through the IL and the
AP [3], but do not coincide with the GPS. E) Sox4 is expressed in
the mouse AP but it is not a marker of the GPS niche. F) Western
blot of GFRa2 and Neurturin (NTN) in rat and human
adenopituitary. Hela cells are a human positive control for
GFRa2. PRL has a slight interspecies difference in MW.
Found at: doi:10.1371/journal.pone.0004815.s002 (1.71 MB
PDF)
Figure S3 Differentiation and proliferation properties of
GFRa2-purified cells in vitro. A) The spheroids are clonal: A
representative experiment is shown where GFRa2+ cells were
diluted in SpherM to 18 cells/ml and seeded into the first column
of a 24-well dish. Further dilutions 1:2 were performed in the
following wells. Five days later all the spheroids per well were
counted (white numbers in the middle of the wells) and
photographed to be able to appreciate an approximate number
of cells/spheroid. In those wells where more than 4 spheroids were
found, a picture of four of them is shown. B) GFRa2 spheroids
express Prop1 and thin lines of b-Catenin and are negative for
PRL. C) Neurturin (NTN), the GFRa2 ligand, functions as a
physiological promoter of spheroid formation when cells are
cultured under sub-optimal conditions (0.56: medium diluted by
half) of SpherM culture media. D) Three ways of culturing MACS
purified GFRa2+ cells render different phenotypes: a) In uncoated
dishes with SpherM, GFRa2+ grow as spheroids as described; b)
cultured on gelatin-coated dishes using 50% of conditioned
medium from MEFs (MEFM), they attach to the surface and
grow as GFRa2+/Prop1+ scattered cells. However, with passages
some differentiated groups of cells forming cord-like structures or
red-pigmented colonies appear and the scattered GPS cell number
is less; c) when cultured directly on top of mitomycin-treated MEFs
(as frequently used for embryonic stem cells), GFRa2+ cells form
colonies that present cilia in the apical pole (Supplementary Video
6). E) Adding Esgro to the MEFM (MEFM+E), the cells did not
attach to the gelatin-coated surface, but grew slowly but steadily as
compact spheres. They were passaged every 25 days. We show
here four independent cultures five days after passage. As
expected, GPS cells cultured on top of MEF carried on with
passages forming colonies (black arrows), although some isolated
differentiated cells appeared.
Found at: doi:10.1371/journal.pone.0004815.s003 (1.32 MB
PDF)
Figure S4 Cdk4 null mouse but not Cdk4(R/R) has hypopitu-
itarism A) Sagittal microphotographs of pituitaries from Cdk4(+/
+), Cdk4(n/n) and Cdk4(R/R) 2-month-old mice. B) The total
number of hormone-producing cells is decreased in young (2–4
months-old) Cdk4-deficient mouse pituitaries and they have
smaller pituitaries (panel A and Figure 6). However, the relative
percentage of hormone-producing cells is not grossly altered in
Cdk4-deficient mice, suggesting an overall deficiency in the
production of all these cells from these progenitors. C) Adult
female mice present a physiological increase in lactotroph cells in
comparison with males that is maintained in the Cdk4-null mice,
in spite of having a much less number of total lactotrophs.
Cdk4(R/R) mice recover normal amount of lactotrophs. In the
left, serum prolactin levels in the animals were analyzed by
immunoassay. D) Representative images of hormone-producing
cells in Cdk4(n/n) mice.
Found at: doi:10.1371/journal.pone.0004815.s004 (0.34 MB
PDF)
Video S1 Three dimensional reconstruction of the rat AP niche
using b-Catenin staining (green).
Found at: doi:10.1371/journal.pone.0004815.s005 (1.81 MB AVI)
Video S2 Three dimensional reconstruction of the rat AP niche
using all channels together, DAPI (Nuclei) blue, GFRa2 (red
membrane staining), and b-Catenin (green).
Found at: doi:10.1371/journal.pone.0004815.s006 (1.78 MB
MPG)
Video S3 Spheroid with beating cilia in one pole.
Found at: doi:10.1371/journal.pone.0004815.s007 (1.05 MB AVI)
Video S4 Hollow spheroid moving against another.
Found at: doi:10.1371/journal.pone.0004815.s008 (5.24 MB AVI)
Video S5 Hollow spheroid moving fast through the culture dish.
Found at: doi:10.1371/journal.pone.0004815.s009 (3.55 MB AVI)
Video S6 Compact spheroid with cilia.
Found at: doi:10.1371/journal.pone.0004815.s010 (2.32 MB AVI)
Video S7 Colony of GFRa2+ cells grown on top of mitomycin-
treated MEFs for two weeks, with cilia beating on the surface.
Found at: doi:10.1371/journal.pone.0004815.s011 (2.74 MB AVI)
Methods S1
Found at: doi:10.1371/journal.pone.0004815.s012 (8.22 MB
DOC)
Table S1 List of Antibodies and dilutions. Primary Antibodies
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PLoS ONE | www.plosone.org 14 March 2009 | Volume 4 | Issue 3 | e4815Found at: doi:10.1371/journal.pone.0004815.s013 (0.06 MB
DOC)
Table S2 List of secondary antibodies and related reagents.
Found at: doi:10.1371/journal.pone.0004815.s014 (0.04 MB
DOC)
Table S3 Oligonucleotides used to analyze gene expression by
RT-PCR.
Found at: doi:10.1371/journal.pone.0004815.s015 (0.03 MB
DOC)
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